ペット用癌治療薬の世界市場の動向・予測 (2022年～2028年)：治療薬タイプ・ペットタイプ・投与モード・用途・地域別

ペット用癌治療薬市場の成長は、リンパ腫やメラノーマなど、一般的な疾患の治療のためのパイプライン薬が多くあることに起因しています。また、民間および政府機関が共同で犬・猫用の新薬の開発に取り組んでいることも、予測期間中の市場成長を促進する主な要因となっています。一方で、ペットの病気に関する認知度の低さ、コストの高さ、薬剤の副作用などが、市場成長を抑制する要因となっています。

当レポートでは、世界のペット用癌治療薬の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、パイプラインの分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提因子

第2章 市場の展望

第3章 市場力学・法規制・動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 主なハイライト
• パイプライン分析
• 規制ガイドライン
• ペットの癌予防のためのイニシアチブ
• ペットの癌のための承認済み標的療法
• 疫学

第4章 世界のペット用癌治療薬市場：治療薬タイプ別

• 化学療法
• 標的療法
• 併用療法
• 免疫療法

第5章 世界のペット用癌治療薬市場：ペットタイプ別

• 猫
• 犬
• 馬

第6章 世界のペット用癌治療薬市場：投与モード別

• 経口
• 静脈内
• 局所

第7章 世界のペット用癌治療薬市場：用途別

• リンパ腫
• マスト細胞癌
• 黒色腫
• 乳腺癌および扁平上皮癌
• その他

第8章 世界のペット用癌治療薬市場：地域別

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• ヒートマップ分析
• 市場シェア分析（3x3マトリックス）
• 企業プロファイル
  • Aratana Therapeutics, Inc.
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • Morphogenesis, Inc.
  • VetDC, Inc.
  • Karyopharm Therapeutics, Inc.
  • Rhizen Pharmaceuticals SA
  • Regeneus Ltd.
  • Oasmia Pharmaceuticals AB
  • Zoetis
• アナリストの見解

第10章 セクション

The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.

Market Dynamics

The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2021, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.

Key features of the study:

This report provides in-depth analysis of pet cancer therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global pet cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market

Detailed Segmentation:

Global Pet Cancer Therapeutics Market, By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

Global Pet Cancer Therapeutics Market, By Pet Type:

Cat

Dog

Horse

Global Pet Cancer Therapeutics Market, By Mode of Administration:

Oral

Intravenous

Topical

Global Pet Cancer Therapeutics Market, By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

Global Pet Cancer Therapeutics Market, By Geography:

North America

By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

By Pet Type:

Cat

Dog

Horse

By Mode of Administration:

Oral

Intravenous

Topical

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Country:

U.S.

Canada

Latin America

By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

By Pet Type:

Cat

Dog

Horse

By Mode of Administration:

Oral

Intravenous

Topical

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

By Pet Type:

Cat

Dog

Horse

By Mode of Administration:

Oral

Intravenous

Topical

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

By Pet Type:

Cat

Dog

Horse

By Mode of Administration:

Oral

Intravenous

Topical

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

By Pet Type:

Cat

Dog

Horse

By Mode of Administration:

Oral

Intravenous

Topical

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Country:

GCC

Israel

Rest of Middle East

Africa

By Therapy Type:

Chemotherapy

Targeted Therapy

Combination Therapy

Immunotherapy

By Pet Type:

Cat

Dog

Horse

By Mode of Administration:

Oral

Intravenous

Topical

By Application:

Lymphoma

Mast Cell Cancer

Melanoma

Mammary and Squamous Cell Cancer

Others

By Country:

South Africa

Central Africa

North Africa

Company Profiles

Aratana Therapeutics, Inc.*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

AB Science

Boehringer Ingelheim International GmbH

Zenoaq

Morphogenesis, Inc.

VetDC, Inc.

Karyopharm Therapeutics, Inc.

Rhizen Pharmaceutical SA

Regeneus Ltd.

Oasmia Pharmaceuticals AB

Zoetis

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Therapy Type
  • Market Snippet, By Pet Type
  • Market Snippet, By Mode of Administration
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Key Highlights
• Pipeline Analysis
• Regulatory Guidelines
• Initiatives for Prevention of Pet Cancer
• Approved Targeted Therapies for Pet Cancer
• Epidemiology

4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Chemotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Targeted Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Combination Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Pet Cancer Therapeutics Market, By Pet Type, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Cat
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Dog
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Horse
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Pet Cancer Therapeutics Market, By Application, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Lymphoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Mast Cell Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Melanoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Mammary and Squamous Cell Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Pet Cancer Therapeutics Market, By Region, 2017 - 2028, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of APAC
• Middle East
  • Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Pet Type, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Mode of Administration, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Aratana Therapeutics, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • AB Science
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Boehringer Ingelheim International GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Zenoaq
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Morphogenesis, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • VetDC, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Karyopharm Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Rhizen Pharmaceuticals SA
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Regeneus Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Oasmia Pharmaceuticals AB
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Zoetis
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
• Analyst Views

10. Section

• References
• Research Methodology
• About us and Sales Contact